Inhibition of lipid peroxidation in central nervous system trauma and ischemia

Journal of the Neurological Sciences

Volumn 134, Issue SUPPL., 1995, Pages 79-83

  Hall, Edward D ^a  

^a PFIZER INC   (United States)

Author keywords

Antioxidant; Cerebral ischemia; Head injury; Lipid peroxidation; Subarachnoid hemorrhage; Tirilazad mesylate

Indexed keywords

ANTIOXIDANT; PREGNANE DERIVATIVE; TIRILAZAD;

ANIMAL; BRAIN INJURY; BRAIN ISCHEMIA; DRUG EFFECT; HUMAN; LIPID PEROXIDATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIOXIDANTS; BRAIN INJURIES; BRAIN ISCHEMIA; HUMANS; LIPID PEROXIDATION; PREGNATRIENES;

EID: 0029433307     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00211-J     Document Type: Article

References (44)

1. Effects of treatment with U-74006F on neurological recovery following experimental spinal cord injury
2. Effect of delayed administration of U-74006F (tirilazad mesvlate) on recovery of locomotor function following experimental spinal cord injury
3. Lipid peroxidation, protein kinase C and cerebral vasospasm
4. Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells
5. The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat
6. Effectiveness of post-ischemic 21-aminosteroid U-74006F in preventing reperfusion brain edema
7. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury
8. Central nervous system trauma and stroke. 1. Biochemical considerations for oxygen radical formation and lipid peroxidation
9. The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia
10. The free radical pathology and the microcirculation in the major central nervous system disorders
11. Effects of a 21-aminosteroid (U-74006F) on cerebral metabolites and edema after severe experimental head trauma
12. Effects of the 21-aminosteroid U-74006F on post-traumatic spinal cord ischemia in cats
13. The neuroprotective pharmacology of methylprednisolone: a review
14. Central nervous system trauma and stroke. 11. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation
15. Free radicals in CNS injury
16. Effects of the non-glucocorticoid 21-aminosteroid U-74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage
17. 21-Aminosteroid lipid peroxidation inhibitor U-74006F protects against cerebral ischemia in gerbils
18. Effects of the 21-aminosteroid U-74006F on experimental head injury in mice
19. Correlation between attenuation of post-traumatic spinal cord ischemia and preservation of vitamin E by the 21-aminosteroid U-74006F: evidence for an in vivo antioxidant action
20. Effect of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils
21. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury
22. Therapeutic potential of the lazaroids (21-aminosteroids) in CNS trauma, ischemia and subarachnoid hemorrhage
23. Blocking weight-induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U-74006F
24. A dosage study of the effect of the 21-aminosteroid U-74006F on chronic cerebral vasospasm in a primate model
25. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot
26. Tirilazad reduces brain edema after middle cerebral artery occlusion in hypertensive rats
27. A randomized double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe/Australia/New Zealand
28. Tirilazad mesylate protects endothelium from damage by reactive oxygen
29. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a “two-hemorrhage” model in beagle dogs
30. The novel 21-aminosteroid U-74006F attenuates cerebral edema and improves survival after brain injury in the rat
31. Effect of tirilazad mesylate on middle cerebral artery occlusion/reperfusion in non-human primates
32. Dose-response analysis of the 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia
33. Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers
34. Effect of U-74006F on neurological function and brain edema after fluid percussion injury in rats
35. Free radicals and brain damage
36. U-74006F, an inhibitor of lipid peroxidation, protects against lesion development following experimental stroke in the cat: histological and metabolic analysis
37. Direct measurement of hydroxyl radical levels, lipid peroxidation and blood-brain barrier disruption following unilateral head injury in the rat
38. A trial of the 21-aminosteroid U-74006F in a primate model of chronic cerebral vasospasm
39. Tinlazad treatment does not decrease early brain injury after transient focal ischemia in cats
40. Effect of the non-glucocorticoid 21-aminosteroid U-74006F on experimental cerebral vasospasm
41. Tirilazad reduces cortical infarction after transient, but not permanent focal cerebral ischemia in rats
42. 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia
43. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats
44. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage